Completed PHASE4 INTERVENTIONAL 1-arm NCT01524601

The Rosuvastatin In TrAnsplant Recipients Study (RITA)

The RITA-study -- An Open Study to Evaluate the Blood Lipid Lowering Effect of Rosuvastatin Versus Fluvastatin and the Bilateral Interaction Between Everolimus and Rosuvastatin in Renal Transplant Recipients

Sponsor: Oslo University Hospital

Conditions Disorder Related to Renal Transplantation Hypercholesterolemia

Interventions Rosuvastatin

Updated 5 times since 2017 Last updated: Oct 11, 2012 Started: Feb 29, 2012 Primary completion: Oct 31, 2012 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Disorder Related to Renal Transplantation and Hypercholesterolemia, this trial is completed. The trial is conducted by Oslo University Hospital and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital
University of Oslo School of Pharmacy

Data source: University of Oslo School of Pharmacy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway